Your browser doesn't support javascript.
loading
Clinical effect of early administration of tocilizumab following the initiation of corticosteroid therapy for patients with COVID-19.
Kawamata, Takaya; Tanino, Yoshinori; Nikaido, Takefumi; Minemura, Hiroyuki; Sato, Yuki; Togawa, Ryuichi; Watanabe, Natsumi; Yamada, Ryuki; Sato, Riko; Onuma, Takumi; Tomita, Hikaru; Saito, Mikako; Rikimaru, Mami; Suzuki, Yasuhito; Tsukada, Yasuhiko; Nakamura, Kiwamu; Kanemitsu, Keiji; Iseki, Ken; Shibata, Yoko.
Afiliação
  • Kawamata T; Department of Pulmonary Medicine, Japan. Electronic address: kawamata@fmu.ac.jp.
  • Tanino Y; Department of Pulmonary Medicine, Japan. Electronic address: ytanino@fmu.ac.jp.
  • Nikaido T; Department of Pulmonary Medicine, Japan. Electronic address: taken@fmu.ac.jp.
  • Minemura H; Department of Pulmonary Medicine, Japan. Electronic address: hiromine@fmu.ac.jp.
  • Sato Y; Department of Pulmonary Medicine, Japan. Electronic address: yukisato@fmu.ac.jp.
  • Togawa R; Department of Pulmonary Medicine, Japan. Electronic address: ryuichi@fmu.ac.jp.
  • Watanabe N; Department of Pulmonary Medicine, Japan. Electronic address: natsumiw@fmu.ac.jp.
  • Yamada R; Department of Pulmonary Medicine, Japan. Electronic address: aigis05@fmu.ac.jp.
  • Sato R; Department of Pulmonary Medicine, Japan. Electronic address: riko-f@fmu.ac.jp.
  • Onuma T; Department of Pulmonary Medicine, Japan. Electronic address: takumi02@fmu.ac.jp.
  • Tomita H; Department of Pulmonary Medicine, Japan. Electronic address: hikaru-t@fmu.ac.jp.
  • Saito M; Department of Pulmonary Medicine, Japan. Electronic address: saito-m@fmu.ac.jp.
  • Rikimaru M; Department of Pulmonary Medicine, Japan. Electronic address: mami-r@fmu.ac.jp.
  • Suzuki Y; Department of Pulmonary Medicine, Japan. Electronic address: yasuyasu@fmu.ac.jp.
  • Tsukada Y; Department of Emergency and Critical Care Medicine, Japan. Electronic address: ytsukada@fmu.ac.jp.
  • Nakamura K; Department of Infection Control, Fukushima Medical University, Hikarigaoka 1, Fukushima, 960-1295, Japan. Electronic address: kinakamu@fmu.ac.jp.
  • Kanemitsu K; Department of Infection Control, Fukushima Medical University, Hikarigaoka 1, Fukushima, 960-1295, Japan. Electronic address: kane2@fmu.ac.jp.
  • Iseki K; Department of Emergency and Critical Care Medicine, Japan. Electronic address: ken@fmu.ac.jp.
  • Shibata Y; Department of Pulmonary Medicine, Japan. Electronic address: shibatay@fmu.ac.jp.
J Infect Chemother ; 28(12): 1639-1644, 2022 Dec.
Article em En | MEDLINE | ID: mdl-36057415
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: J Infect Chemother Assunto da revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tratamento Farmacológico da COVID-19 Tipo de estudo: Observational_studies Limite: Humans Idioma: En Revista: J Infect Chemother Assunto da revista: MICROBIOLOGIA / TERAPIA POR MEDICAMENTOS Ano de publicação: 2022 Tipo de documento: Article